Decode the Environment Variation of Targeted Aldosterone Inducer and siLencer

计划入组 100 人 · 首次发布于 2026 年 8 月 6 日

A Phase I Trial of QLS1410 in Healthy Chinese Adults and Participants With Mild Essential Hypertension

计划入组 78 人 · 首次发布于 2025 年 9 月 3 日

CYP19A1 (Cytochrome P450 Family 19 Subfamily A Member 1) Gene and Pharmacogenetics of Response to Testosterone Therapy

计划入组 105 人 · 首次发布于 2011 年 6 月 22 日

CYP11B2 inhibitors (ElexoPharm)

CYP11A1 inhibitors(National Jewish Health)

aldosterone synthase (CYP11B2) inhibitors (cardiovascular disease)

Recordati's Isturisa Approved in South Korea for Cushing's Disease

FDA Grants Priority Review to Crinecerfont for Congenital Adrenal Hyperplasia

AstraZeneca Completes $1.3 Billion Acquisition of CinCor Pharma for Hypertension Drug Baxdrostat